COVID-19: Newly Authorized Device From OraSure Subsidiary Allows At-Home Collection Of Saliva Samples

The US Food and Drug Administration has granted an emergency use authorization (EUA) to a device that allows the home collection of saliva for COVID-19 diagnosis.

OraSure Technologies, Inc. announced the authorization of the OMNIgene ORAL saliva collection and stabilization device, which was developed by OraSure subsidiary DNA Genotek, on 19 October. The EUA allows the device to be used to collect saliva for COVID-19 diagnosis as part of another EUA-authorized diagnostic's home collection kit